Use of Bemitil in patients with progressive muscular dystrophies
V. S. Lobzin, L. A. Saikova, M. L. Chukhlovina, V. G. Pustozerov · 1992 · Lik Sprava. (4):85–87. PMID 1441389
What does this source report?
Reports changes in lipid peroxidation and discusses glucose metabolism in patients receiving Bemitil.
- Population and setting
- 22 patients with progressive myodystrophy
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- The abstract does not establish a randomized comparison or durable disease-modifying benefit.
- The 1991 and 1992 publications may share patients; they are not assumed to be independent replications.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and abstract checked; full methods and risk of bias remain unreviewed.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: V. S. Lobzin, L. A. Saikova, M. L. Chukhlovina, V. G. Pustozerov. Use of Bemitil in patients with progressive muscular dystrophies Lik Sprava. (4):85–87. PMID 1441389 1992.
Molekul research summary: https://molekul.io/research/acto-1441389. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry